US Specialty Generics Market Insights and Forecast Report Till 2028

According to the recent report by IMARC Group, titled United States Specialty Generics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, the United States specialty generics market size reached US$ 26.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 47.0 Billion by 2028, exhibiting a growth rate (CAGR) of 9.6% during 2023-2028.

Specialty generics represent off-patented drugs that are bioequivalent to branded medications in terms of strength, quality, dosage, form, effect, intended use, side effects, route of administration, etc. They generally need special handling, monitoring, and prior authorization to order them. In addition to this, specialty generics are less expensive as compared to their counterparts as they do not require extensive manufacturing and marketing costs. Furthermore, these drugs are utilized to treat chronic health conditions, such as autoimmune diseases, cancer, epilepsy, HIV, hepatitis, multiple sclerosis, rheumatoid arthritis, etc. Consequently, specialty generics are gaining traction across the US.

United States Specialty Generics Market Trends:

The expanding geriatric population and the growing number of branded drugs nearing their expiration dates are primarily driving the US specialty generics market. Additionally, the launch of various favorable policies by government bodies in the country to develop affordable treatment options is catalyzing the market growth. Besides this, they are also providing incentives to physicians and pharmacists for promoting generic substitution, which is acting as another significant growth-inducing factor. Moreover, the escalating demand for re-innovated generics with reduced intra- and inter-patient variability is augmenting the market growth in the US. Apart from this, the introduction of biosimilar drugs by the leading manufacturers and the rising investments in R&D activities are anticipated to fuel the US specialty generics market over the forecasted period.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Route of Administration:

  • Injectables
  • Oral
  • Others

Breakup by Therapeutic Application:

  • Oncology
  • Hepatitis
  • Multiple Sclerosis
  • HIV
  • Other Autoimmune Diseases
  • Others

Breakup by Distribution channel:

  • Retail Pharmacies
  • Specialty Pharmacies
  • Hospital Pharmacies

Get a Free Sample Copy of this Report:

Key Highlights of the Report:                                                           

  • Market Performance (2017-2022)
  • Market Outlook (2023-2028)
  • Market Trends
  • Market Drivers and Success Factors
  • The Impact of COVID-19 on the Global Market
  • Value Chain Analysis
  • Structure of the Global Market
  • Comprehensive mapping of the competitive landscape

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Table of Content:

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Global Specialty Generics Market: Introduction

    4.1    What are Specialty Generic Drugs?
    4.2    Types of Specialty Generics
5   Why are Specialty Generics So Lucrative?
6   Global Specialty Generics Market

    6.1    Market Overview
    6.2    Market Performance
    6.3    Market Breakup by Route of Administration
    6.4    Market Breakup by Therapeutic Application
    6.5    Market Breakup by Distribution Channel
    6.6    Market Breakup by Region
    6.7    Market Forecast
7   US Specialty Generics Market
    7.1    Market Overview
    7.2    Market Performance
    7.3    Impact of COVID-19
    7.4    Market Breakup by Route of Administration
    7.5    Market Breakup by Therapeutic Application
    7.6    Market Breakup by Distribution Channel
    7.7    Market Forecast
    7.8    SWOT Analysis
        7.8.1    Overview
        7.8.2    Strengths
        7.8.3    Weaknesses
        7.8.4    Opportunities
        7.8.5    Threats
    7.9    Value Chain Analysis
    7.10    Porters Five Forces Analysis
        7.10.1    Overview
        7.10.2    Bargaining Power of Buyers
        7.10.3    Bargaining Power of Suppliers
        7.10.4    Degree of Competition
        7.10.5    Threat of New Entrants
        7.10.6    Threat of Substitutes
    7.11    Key Market Drivers and Success Factors
8   Market Breakup by Route of Administration
    8.1    Injectables
        8.1.1    Market Trends
        8.1.2    Market Forecast
    8.2    Oral
        8.2.1    Market Trends
        8.2.2    Market Forecast
    8.3    Others
        8.3.1    Market Trends
        8.3.2    Market Forecast
9   Market Breakup by Therapeutic Application
    9.1    Oncology
        9.1.1    Market Trends
        9.1.2    Market Forecast
    9.2    Hepatitis
        9.2.1    Market Trends
        9.2.2    Market Forecast
    9.3    Multiple Sclerosis
        9.3.1    Market Trends
        9.3.2    Market Forecast
    9.4    HIV
        9.4.1    Market Trends
        9.4.2    Market Forecast
    9.5    Other Autoimmune Diseases
        9.5.1    Market Trends
        9.5.2    Market Forecast
    9.6    Others
        9.6.1    Market Trends
        9.6.2    Market Forecast
10  Market Breakup by Distribution Channel
    10.1    Retail Pharmacies
        10.1.1    Market Trends
        10.1.2    Market Forecast
    10.2    Specialty Pharmacies
        10.2.1    Market Trends
        10.2.2    Market Forecast
    10.3    Hospital Pharmacies
        10.3.1    Market Trends
        10.3.2    Market Forecast
11  Competitive Landscape
    11.1    Market Structure
    11.2    Key Players
    11.3    Profiles of Key Players

About Us:                                                              

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States